Equal Justice for United States Military Personnel Act of 2009

Drug safety and drug counterfeiting including H.R. 579, the Food and Drug Administration Globalization Act; Drug importation including S. 525/H.R. 1298, the Pharmaceutical Market Access and Drug Safety Act of 2009; S. 1232, Pharmaceutical Market Access and Drug Safety Act of 2009; Authorized generics including H.R. 573; S. 501, Fair Prescription Drug Competition Act; Drug company settlements including S. 369, Preserve Access to Affordable Generics Act; H.R. 1706, Protecting Consumer Access to Generic Drugs Act, and FY 2011 Financial Services and General Government Appropriations bill; Prescription drug advertising; Federal preemption for prescription drugs; and Legislation concerning civil litigation including S. 357, Sunshine in Litigation Act of 2009.

Client expense: Not reported · Firm income: $120,000

Government targets: HOUSE OF REPRESENTATIVES, SENATE

Drug safety and drug counterfeiting including H.R. 579, the Food and Drug Administration Globalization Act; Drug importation including S. 525/H.R. 1298, the Pharmaceutical Market Access and Drug Safety Act of 2009; S. 1232, Pharmaceutical Market Access and Drug Safety Act of 2009; 340 B Program including H.R. 4213, American Jobs and Closing Tax Loopholes Act; Authorized generics including H.R. 573; S. 501, Fair Prescription Drug Competition Act; Drug company settlements including S. 369, Preserve Access to Affordable Generics Act; H.R. 1706, Protecting Consumer Access to Generic Drugs Act, and FY 2011 Financial Services and General Government Appropriations bill; Prescription drug advertising; Federal preemption for prescription drugs; Legislation affecting telemedicine; and Legislation concerning civil litigation including S. 357, Sunshine in Litigation Act of 2009.

Client expense: Not reported · Firm income: $70,000

Government targets: HOUSE OF REPRESENTATIVES, SENATE

Drug safety and drug counterfeiting including H.R. 579, the Food and Drug Administration Globalization Act; Drug importation including S. 525/H.R. 1298, the Pharmaceutical Market Access and Drug Safety Act of 2009; S. 1232, Pharmaceutical Market Access and Drug Safety Act of 2009; 340 B Program including H.R. 4213, American Jobs and Closing Tax Loopholes Act; Authorized generics including H.R. 573; S. 501, Fair Prescription Drug Competition Act; Drug company settlements including S. 369, Preserve Access to Affordable Generics Act; H.R. 1706, Protecting Consumer Access to Generic Drugs Act, and FY 2011 Financial Services and General Government Appropriations bill; Stem cell research including S. 487/H.R. 873, Stem Cell Research Enhancement Act of 2009; Prescription drug advertising; Federal preemption for prescription drugs; and Legislation concerning civil litigation including S. 357, Sunshine in Litigation Act of 2009.

Client expense: Not reported · Firm income: $50,000

S. 718, H.R. 3764, Civil Access to Justice Act of 2009 H. R. 984, S. 417, the State Secrets Protection Act HR 429, S. 446, A bill to permit the televising of Supreme Court proceedings. H.R. 156, Stop the Congressional Pay Raise Act H.R. 215, Congressional Pay Reform Act of 2009 H.R. 282, Delay Congressional Pay Raise Act S. 102, S. 317, S. 620, A bill to repeal the provision of law that provides automatic pay adjustments for Members of Congress. S. 2725, Federal Judicial Fairness Act HR 569, S.357, Equal Justice for the Military Act - provides service members with the same opportunity that the government has to petition the Supreme Court for review of a court martial H.R. 1515 ,to assist State Courts in Administration of Justice H.R. 3662, S. 1653, the Federal Judgeship Act of 2009 H. Res 473, Reaffirmation of American Independence (foreign judgments) H. R. 4115, Open Access to Courts Act of 2009, to provide restoration of notice pleading S. 1504, Notice Pleading Restoration Act of 2009 H.R. 2728, William Orton Law Library Improvement and Modernization Act Proposed appointment of new Chair, suggested reform projects and other proposed start-up activities for the newly reconstituted Administrative Conference of the United States. H.R. 2850, the Administrative Law Judges Retirement Act of 2009, legislation that would provide for enhanced retirement benefits for administrative law judges. The appointment and examination process for ALJssupports improvements in the process. H.R. 4113, Federal Courts Jurisdiction and Venue Clarification Act

Client expense: $320,000 · Firm income: Not reported

Fair Sentencing Act (S. 1789); Tribal Law and Order Act (S. 797, H.R. 1924) - all provisions; Equal Justice for Our Military Act (S. 357, HR 569) - all provisions; Justice For All Act Reauthorization; State Secrets Protection Act (S. 417) - all provisions; U.S. Patriot Act and Domestic Surveillance Laws; Indigent Defense, Over-criminalization of Conduct and Over-federalization of Criminal law; Military Commissions Act of 2009; Strengthening Forensic Science in the U.S.; Judiciously Using Surveillance Tools in Counterterrorism Efforts Act (S. 1686) - all provisions; FY2011 Commerce - Justice - Science Appropriations - funding for indigent defense and John R. Justice Prosecutors and Defenders Incentive Act. Compensation for the Federal Judiciary (S. 2725) - all provisions; Universal Access to Methamphetamine Act (H.R. 5678) - all provisions; Drug Courts and Alternatives to Incarceration; Prison Rape Elimination Act regulations; Recording of Interrogations by Federal Law Enforcement; Wall Street Reform and Consumer Protection Act (H.R. 4173, H.R. 4173eas, S. 3217) - all criminal provisions.

Client expense: $50,000 · Firm income: Not reported

Drug safety and drug counterfeiting including H.R. 579, the Food and Drug Administration Globalization Act; Drug importation including S. 525/H.R. 1298, the Pharmaceutical Market Access and Drug Safety Act of 2009; S. 1232, Pharmaceutical Market Access and Drug Safety Act of 2009; Authorized generics including H.R. 573; S. 501, Fair Prescription Drug Competition Act; Drug company settlements including S. 369, Preserve Access to Affordable Generics Act; H.R. 1706, Protecting Consumer Access to Generic Drugs Act; Prescription drug advertising; Federal preemption for prescription drugs; and Legislation concerning civil litigation including S. 357, Sunshine in Litigation Act of 2009.

Client expense: Not reported · Firm income: $60,000

Government targets: HOUSE OF REPRESENTATIVES, SENATE

Drug safety and drug counterfeiting including H.R. 579, the Food and Drug Administration Globalization Act; Drug importation including S. 525/H.R. 1298, the Pharmaceutical Market Access and Drug Safety Act of 2009; S. 1232, Pharmaceutical Market Access and Drug Safety Act of 2009; 340 B Program including H.R. 4213, American Jobs and Closing Tax Loopholes Act; Authorized generics including H.R. 573; S. 501, Fair Prescription Drug Competition Act; Drug company settlements including S. 369, Preserve Access to Affordable Generics Act; H.R. 1706, Protecting Consumer Access to Generic Drugs Act; Prescription drug advertising; Federal preemption for prescription drugs; Legislation affecting telemedicine; and Legislation concerning civil litigation including S. 357, Sunshine in Litigation Act of 2009.

Client expense: Not reported · Firm income: $40,000

Drug safety and drug counterfeiting including H.R. 579, the Food and Drug Administration Globalization Act; Drug importation including S. 525/H.R. 1298, the Pharmaceutical Market Access and Drug Safety Act of 2009; S. 1232, Pharmaceutical Market Access and Drug Safety Act of 2009; 340 B Program including H.R. 4213, American Jobs and Closing Tax Loopholes Act; Authorized generics including H.R. 573; S. 501, Fair Prescription Drug Competition Act; Drug company settlements including S. 369, Preserve Access to Affordable Generics Act; H.R. 1706, Protecting Consumer Access to Generic Drugs Act; Stem cell research including S. 487/H.R. 873, Stem Cell Research Enhancement Act of 2009; Prescription drug advertising; Federal preemption for prescription drugs; and Legislation concerning civil litigation including S. 357, Sunshine in Litigation Act of 2009.

Client expense: Not reported · Firm income: $50,000

S. 718, H.R. 3764, Civil Access to Justice Act of 2009 H. R. 984, S. 417, the State Secrets Protection Act HR 429, S. 446, A bill to permit the televising of Supreme Court proceedings. H.R. 156, Stop the Congressional Pay Raise Act H.R. 215, Congressional Pay Reform Act of 2009 H.R. 282, Delay Congressional Pay Raise Act S. 102, S. 317, S. 620, A bill to repeal the provision of law that provides automatic pay adjustments for Members of Congress. S. 2725, Federal Judicial Fairness Act HR 569, S.357, Equal Justice for the Military Act - provides service members with the same opportunity that the government has to petition the Supreme Court for review of a court martial H.R. 1515 ,to assist State Courts in Administration of Justice H.R. 3662, S. 1653, the Federal Judgeship Act of 2009 H. Res 473, Reaffirmation of American Independence (foreign judgments) H. R. 4115, Open Access to Courts Act of 2009, to provide restoration of notice pleading S. 1504, Notice Pleading Restoration Act of 2009 H.R. 2728, William Orton Law Library Improvement and Modernization Act Proposed appointment of new Chair or Acting Chair and other proposed start-up activities for the newly reconstituted Administrative Conference of the United States. H.R. 2850, the Administrative Law Judges Retirement Act of 2009, legislation that would provide for enhanced retirement benefits for administrative law judges. The appointment and examination process for ALJssupports improvements in the process.

Client expense: $290,000 · Firm income: Not reported

Drug safety and drug counterfeiting including H.R. 579, the Food and Drug Administration Globalization Act; Drug importation including S. 525/H.R. 1298, the Pharmaceutical Market Access and Drug Safety Act of 2009; S. 1232, Pharmaceutical Market Access and Drug Safety Act of 2009; H.R. 3590, Patient Protection and Affordable Care Act. Follow-on biologics including H.R. 1548, the Pathway to Biosimilars Act; S. 726/H.R. 1427, Promoting Innovation and Access to Life-Saving Medicines Act; H.R. 3962, Affordable Health Care for America Act; H.R. 3590, Patient Protection and Affordable Care Act; H.R. 4872, the Health Care and Education Reconciliation Act of 2010. Physician payment disclosure including S. 301, Physician Payments Sunshine Act of 2009; H.R. 3962, Affordable Health Care for America Act; H.R. 3590, Patient Protection and Affordable Care Act; H.R. 4872, the Health Care and Education Reconciliation Act of 2010. Comparative effectiveness including S.1213, Patient-Centered Outcomes Research Act of 2009; H.R. 3962, Affordable Health Care for America Act; H.R. 3590, Patient Protection and Affordable Care Act; H.R. 4872, the Health Care and Education Reconciliation Act of 2010. Authorized generics including H.R. 573; S. 501, Fair Prescription Drug Competition Act; Drug company settlements including S. 369, Preserve Access to Affordable Generics Act; H.R. 1706, Protecting Consumer Access to Generic Drugs Act; H.R. 3962, Affordable Health Care for America Act; H.R. 3590, Patient Protection and Affordable Care Act; H.R. 4872, the Health Care and Education Reconciliation Act of 2010. Health care reform including H.R. 3200, America's Affordable Health Choices Act; S___, Affordable Health Choices Act; and S. ___, America's Healthy Future Act; H.R. 3962, Affordable Health Care for America Act; and H.R. 3590, Patient Protection and Affordable Care Act; H.R. 4872, the Health Care and Education Reconciliation Act of 2010. Prescription drug advertising; Federal preemption for prescription drugs; and Legislation concerning civil litigation including S. 357, Sunshine in Litigation Act of 2009.

Drug safety and drug counterfeiting including H.R. 579, the Food and Drug Administration Globalization Act; Drug importation including S. 525/H.R. 1298, the Pharmaceutical Market Access and Drug Safety Act of 2009; S. 1232, Pharmaceutical Market Access and Drug Safety Act of 2009; H.R. 3590, Patient Protection and Affordable Care Act. Follow-on biologics including H.R. 1548, the Pathway to Biosimilars Act; S. 726/H.R. 1427, Promoting Innovation and Access to Life-Saving Medicines Act; H.R. 3962, Affordable Health Care for America Act; H.R. 3590, Patient Protection and Affordable Care Act; H.R. 4872, the Health Care and Education Reconciliation Act of 2010. Physician payment disclosure including S. 301, Physician Payments Sunshine Act of 2009; H.R. 3962, Affordable Health Care for America Act; H.R. 3590, Patient Protection and Affordable Care Act; H.R. 4872, the Health Care and Education Reconciliation Act of 2010. Comparative effectiveness including S. 1259, Preserving Access to Targeted, Individualized, and Effective New Treatments and Services Act of 2009; S. 1213, Patient-Centered Outcomes Research Act of 2009; H.R. 3962, Affordable Health Care for America Act; H.R. 3590, Patient Protection and Affordable Care Act; H.R. 4872, the Health Care and Education Reconciliation Act of 2010. Authorized generics including H.R. 573; S. 501, Fair Prescription Drug Competition Act; Drug company settlements including S. 369, Preserve Access to Affordable Generics Act; H.R. 1706, Protecting Consumer Access to Generic Drugs Act; H.R. 3962, Affordable Health Care for America Act; H.R. 3590, Patient Protection and Affordable Care Act; H.R. 4872, the Health Care and Education Reconciliation Act of 2010. Health care reform including H.R. 3200, America's Affordable Health Choices Act; S.___, Affordable Health Choices Act; and S.___, America's Healthy Future Act; H.R. 3962, Affordable Health Care for America Act; H.R. 3590, Patient Protection and Affordable Care Act; H.R. 4872, the Health Care and Education Reconciliation Act of 2010. Prescription drug advertising; Federal preemption for prescription drugs; Legislation affecting telemedicine including H.R. 3962, Affordable Health Care for America Act; H.R. 3590, Patient Protection and Affordable Care Act; H.R. 4872, the Health Care and Education Reconciliation Act of 2010. Legislation concerning civil litigation including S. 357, Sunshine in Litigation Act of 2009.

Drug safety and drug counterfeiting including H.R. 579, the Food and Drug Administration Globalization Act; Drug importation including S. 525/H.R. 1298, the Pharmaceutical Market Access and Drug Safety Act of 2009; S. 1232, Pharmaceutical Market Access and Drug Safety Act of 2009; H.R. 3590, Patient Protection and Affordable Care Act. Follow-on biologics including H.R. 1548, the Pathway to Biosimilars Act; S. 726/H.R. 1427, Promoting Innovation and Access to Life-Saving Medicines Act; H.R. 3962, Affordable Health Care for America Act; H.R. 3590, Patient Protection and Affordable Care Act; H.R. 4872, the Health Care and Education Reconciliation Act of 2010. Physician payment disclosure including S. 301, Physician Payments Sunshine Act of 2009; H.R. 3962, Affordable Health Care for America Act; H.R. 3590, Patient Protection and Affordable Care Act; H.R. 4872, the Health Care and Education Reconciliation Act of 2010. Comparative effectiveness including S. 1213, Patient-Centered Outcomes Research Act of 2009; H.R. 3962, Affordable Health Care for America Act; H.R. 3590, Patient Protection and Affordable Care Act; H.R. 4872, the Health Care and Education Reconciliation Act of 2010. Authorized generics including H.R. 573; S. 501, Fair Prescription Drug Competition Act; Drug company settlements including S. 369, Preserve Access to Affordable Generics Act; H.R. 1706, Protecting Consumer Access to Generic Drugs Act; H.R. 3962, Affordable Health Care for America Act; H.R. 3590, Patient Protection and Affordable Care Act; H.R. 4872, the Health Care and Education Reconciliation Act of 2010. Health care reform including H.R. 3200, America's Affordable Health Choices Act; S. , Affordable Health Choices Act; and S. , America's Healthy Future Act; H.R. 3962, Affordable Health Care for America Act; H.R. 3590, Patient Protection and Affordable Care Act; H.R. 4872, the Health Care and Education Reconciliation Act of 2010. Stem cell research including S. 487/H.R. 873, Stem Cell Research Enhancement Act of 2009; Prescription drug advertising; Federal preemption for prescription drugs; and Legislation concerning civil litigation including S. 357, Sunshine in Litigation Act of 2009.

Fair Sentencing Act (S. 1789); Fairness in Cocaine Sentencing Act (HR 3245) - all provisions; Tribal Law and Order Act (S. 797, H.R. 1924) - all provisions; Equal Justice for Our Military Act (S. 357, HR 569) - all provisions; Justice For All Act Reauthorization; State Secrets Protection Act (S. 417) - all provisions; U.S. Patriot Act and Domestic Surveillance Laws; Indigent Defense, Over-criminalization of Conduct and Over-federalization of Criminal law; Strengthening Forensic Science in the U.S.; Judiciously Using Surveillance Tools in Counterterrorism Efforts Act (S. 1686) - all provisions; Attorney-Client Privilege Protection Act (H.R. 4326) - all provisions; The Patient Protection and Affordable Care Act (H.R. 3590) - (S.A. 2792) - all provisions; indigent defense; drug courts; FY2011 Commerce - Justice - Science Appropriations - funding for indigent defense and John R. Justice Prosecutors and Defenders Incentive Act.

Client expense: $50,000 · Firm income: Not reported

Government targets: Bureau of Justice Assistance, HOUSE OF REPRESENTATIVES, Justice, Dept of (DOJ), SENATE

H.R. 429, S. 446, A bill to permit the televising of Supreme Court proceedings. H.R. 156, Stop the Congressional Pay Raise Act H.R. 3662, S. 1653, the Federal Judgeship Act of 2009 H.R. 215, Congressional Pay Reform Act of 2009 H.R. 282, Delay Congressional Pay Raise Act S. 102, S. 317, S. 620, A bill to repeal the provision of law that provides automatic pay adjustments for Members of Congress. HR 569, S.357, Equal Justice for the Military Act (provides service members with the same opportunity that the government has to petition the Supreme Court for review of a court martial that carries serious consequences to the Supreme Court H.R. 984, S. 417, the State Secrets Protection Act H.R. 157, S. 160, the District of Columbia House Voting Rights Act of 2009 S. 718, H.R. 3764, Civil Access to Justice Act of 2009 Draft legislation to establish a new Administrative Law Judge Conference of the United States as an independent agency to assume the responsibility of the United States Office of Personnel Management with respect to Administrative Law Judges, including their testing, selection, and appointment Draft legislation to amend various adjudication provisions of the Administrative Procedure Act Legislative recommendations related to: attorney-client privilege and the Rules Enabling Act H.R. 1515, to assist courts in the States and territories with improving the administration of justice H.Res. 473, Expressing the sense of the House of Representatives that judicial determinations regarding the meaning of the Constitution of the United States should not be based on judgments, laws, or pronouncements of foreign institutions unless such foreign judgments, laws, or pronouncements inform an understanding of the original meaning of the Constitution of the United States. Draft legislation to encourage greater use of federal agency E-rulemaking (electronic rulemaking) Proposed appointment of new Chair or Acting Chair and other proposed start-up activities for the newly reconstituted Administrative Conference of the United States H.R. 2850, the Administrative Law Judges Retirement Act of 2009-legislation that would provide for enhanced retirement benefits for administrative law judges Urged the OPM and to use its authority to make locality adjustments to the basic pay of administrative law judges (ALJs) and to grant ALJs the same national pay raise that was expected to be authorized for the General Schedule for fiscal year 2010. The appointment and examination process for ALJssupports improvements in the process. H. R. 4115, Open Access to Courts Act of 2009, S. 1504, Notice Pleading Restoration Act of 2009 -to provide restoration of notice pleading

Drug safety and drug counterfeiting including H.R. 579, the Food and Drug Administration Globalization Act; Drug importation including S. 525/H.R. 1298, the Pharmaceutical Market Access and Drug Safety Act of 2009; S. 1232, Pharmaceutical Market Access and Drug Safety Act of 2009; Follow-on biologics including H.R. 1548, the Pathway to Biosimilars Act; S. 726/H.R. 1427, Promoting Innovation and Access to Life-Saving Medicines Act; Physician payment disclosure including S. 301, Physician Payments Sunshine Act of 2009; Comparative effectiveness including H.R. 1, the American Recovery and Reinvestment Act; S. 1213, Patient-Centered Outcomes Research Act of 2009; Health information technology including H.R. 1, the American Recovery and Reinvestment Act; Authorized generics including H.R. 573; S. 501, Fair Prescription Drug Competition Act; Drug company settlements indlucing S. 369, Preserve Access to Affordable Generics Act; H.R. 1706, Protecting Consumer Access to Generic Drugs Act; Health care reform including Affordable Health Choices Act, H.R. 3200, America's Affordable Health Choices Act, America's Healthy Future Act; H.R. 3962, Affordable Health Care for America Act; and H.R. 3590, Patient Protection and Affordable Care Act; Prescription drug advertising; Federal preemption for prescription drugs; and Legislation concerning civil litigation including S. 357, Sunshine in Litigation Act of 2009.

Client expense: Not reported · Firm income: $80,000

Drug safety and drug counterfeiting including H.R. 579, the Food and Drug Administration Globalization Act; Drug importation including S. 525/H.R. 1298, the Pharmaceutical Market Access and Drug Safety Act of 2009; S. 1232, Pharmaceutical Market Access and Drug Safety Act of 2009; Follow-on biologics including H.R. 1548, the Pathway to Biosimilars Act; S. 726/H.R. 1427, Promoting Innovation and Access to Life-Saving Medicines Act; Physician payment disclosure including S. 301, Physician Payments Sunshine Act of 2009; Comparative effectiveness including H.R. 1, the American Recovery and Reinvestment Act; S.1213, Patient-Centered Outcomes Research Act of 2009; Health information technology including H.R. 1, the American Recovery and Reinvestment Act; Authorized generics including H.R. 573; S. 501, Fair Prescription Drug Competition Act; Drug company settlements including S. 369, Preserve Access to Affordable Generics Act; H.R. 1706, Protecting Consumer Access to Generic Drugs Act; Health care reform including H.R. 3200, America's Affordable Health Choices Act; S___, Affordable Health Choices Act; and S. ___, America's Healthy Future Act; H.R. 3962, Affordable Health Care for America Act; and H.R. 3590, Patient Protection and Affordable Care Act; Prescription drug advertising; Federal preemption for prescription drugs; and Legislation concerning civil litigation including S. 357, Sunshine in Litigation Act of 2009.

Client expense: Not reported · Firm income: $60,000

Drug safety and drug counterfeiting including H.R. 579, the Food and Drug Administration Globalization Act; Drug importation including S. 525/H.R. 1298, the Pharmaceutical Market Access and Drug Safety Act of 2009; S. 1232, Pharmaceutical Market Access and Drug Safety Act of 2009; Follow-on biologics including H.R. 1548, the Pathway to Biosimilars Act; S. 726/H.R. 1427, Promoting Innovation and Access to Life-Saving Medicines Act; Physician payment disclosure including S. 301, Physician Payments Sunshine Act of 2009; Comparative effectiveness including H.R. 1, the American Recovery and Reinvestment Act; S. 1259, Preserving Access to Targeted, Individualized, and Effective New Treatments and Services Act of 2009; S. 1213, Patient-Centered Outcomes Research Act of 2009; Health information technology including H.R. 1, the American Recovery and Reinvestment Act; Authorized generics including H.R. 573; S. 501, Fair Prescription Drug Competition Act; Drug company settlements including S. 369, Preserve Access to Affordable Generics Act; H.R. 1706, Protecting Consumer Access to Generic Drugs Act; Health care reform including H.R. 3200, America's Affordable Health Choices Act; S.___, Affordable Health Choices Act; and S.___, America's Healthy Future Act; H.R. 3962, Affordable Health Care for America Act; H.R. 3590, Patient Protection and Affordable Care Act; Prescription drug advertising; Federal preemption for prescription drugs; Legislation affecting telemedicine including H.R. 1, the American Recovery and Reinvestment Act; and Legislation concerning civil litigation including S. 357, Sunshine in Litigation Act of 2009.

Client expense: Not reported · Firm income: $100,000

Drug safety and drug counterfeiting including H.R. 579, the Food and Drug Administration Globalization Act; Drug importation including S. 525/H.R. 1298, the Pharmaceutical Market Access and Drug Safety Act of 2009; S. 1232, Pharmaceutical Market Access and Drug Safety Act of 2009; Follow-on biologics including H.R. 1548, the Pathway to Biosimilars Act; S. 726/H.R. 1427, Promoting Innovation and Access to Life-Saving Medicines Act; Physician payment disclosure including S. 301, Physician Payments Sunshine Act of 2009; Comparative effectiveness including H.R. 1, the American Recovery and Reinvestment Act; S. 1213, Patient-Centered Outcomes Research Act of 2009; Health information technology including H.R. 1, the American Recovery and Reinvestment Act; Authorized generics including H.R. 573; S. 501, Fair Prescription Drug Competition Act; Drug company settlements including S. 369, Preserve Access to Affordable Generics Act; H.R. 1706, Protecting Consumer Access to Generic Drugs Act; Health care reform including H.R. 3200, America's Affordable Health Choices Act; S. , Affordable Health Choices Act; and S. , America's Healthy Future Act; H.R. 3962, Affordable Health Care for America Act; H.R. 3590, Patient Protection and Affordable Care Act; Stem cell research including S. 487/H.R. 873, Stem Cell Research Enhancement Act of 2009; Prescription drug advertising; Federal preemption for prescription drugs; and Legislation concerning civil litigation including S. 357, Sunshine in Litigation Act of 2009.

Client expense: Not reported · Firm income: $50,000

Fair Sentencing Act (S. 1789); Fairness in Cocaine Sentencing Act (HR 3245) - all provisions; Tribal Law and Order Act (S. 797, H.R. 1924) - all provisions; Equal Justice for Our Military Act (S. 357, HR 569) - all provisions; Justice For All Act Reauthorization; Justice Integrity Act (S. 495, H.R. 1412) - all provisions; Federal Restricted Buildings and Grounds Improvement Act of 2009 (H.R. 2780) - all provisions; State Secrets Protection Act (S. 417) - all provisions; U.S. Patriot Act and Domestic Surveillance Laws; Indigent Defense, Over-criminalization of Conduct and Over-federalization of Criminal law; Strengthening Forensic Science in the U.S.; National Criminal Justice Commission Act (S. 714) - all provisions; Deferred Prosecution Agreements and Non-Prosecution Agreements; Judicial recusal standards; racial discrimination in the criminal justice system; Judiciously Using Surveillance Tools in Counterterrorism Efforts Act (S. 1686) - all provisions; Accountability in Deferred Prosecution Act (H.R. 1947) - all provisions; Incorporation Transparency and Law Enforcement Assistance Act (S. 569) - all provisions; Strengthening Enforcement for Health Care Fraud Crimes Act (S. 1843)- (S.A. 2787); Attorney-Client Privilege Protection Act (H.R. 4326) - all provisions; The Patient Protection and Affordable Care Act (H.R. 3590) - (S.A. 2792) - all provisions.

Client expense: $50,000 · Firm income: Not reported

Drug Sentencing Reform and Cocaine Kingpin Trafficking Act (HR 265) - all provisions; Fairness in Cocaine Sentencing Act (HR 3245) - all provisions; Tribal Law and Order Act (S. 797, H.R. 1924) - all provisions; Equal Justice for Our Military Act (S. 357, HR 569) - all provisions; Justice For All Act Reauthorization; Justice Integrity Act (S. 495, H.R. 1412) - all provisions; Federal Restricted Buildings and Grounds Improvement Act of 2009 (H.R. 2780) - all provisions; State Secrets Protection Act (S. 417) - all provisions; U.S. Patriot Act and Domestic Surveillance Laws; Indigent Defense, Over-criminalization of Conduct and Over-federalization of Criminal law; Strengthening Forensic Science in the U.S.; National Criminal Justice Commission Act (S. 714) - all provisions; Deferred Prosecution Agreements and Non-Prosecution Agreements.

Client expense: $50,000 · Firm income: Not reported

Government targets: Bureau of Justice Assistance, HOUSE OF REPRESENTATIVES, Justice, Dept of (DOJ), SENATE

H.R. 429, S. 446, A bill to permit the televising of Supreme Court proceedings. S. 657, Sunshine in the Courtroom Act of 2009 H.R. 156, Stop the Congressional Pay Raise Act H.R. 3662, S. 1653, the Federal Judgeship Act of 2009 H.R. 215, Congressional Pay Reform Act of 2009 H.R. 282, Delay Congressional Pay Raise Act S. 102, S. 317, S. 620, A bill to repeal the provision of law that provides automatic pay adjustments for Members of Congress. HR 569, S.357, Equal Justice for the Military Act (provides service members with the same opportunity that the government has to petition the Supreme Court for review of a court martial that carries serious consequences to the Supreme Court H.R. 984, S. 417, the State Secrets Protection Act H.R. 157, S. 160, the District of Columbia House Voting Rights Act of 2009 S. 718, Civil Access to Justice Act of 2009 Draft legislation to establish a new Administrative Law Judge Conference of the United States as an independent agency to assume the responsibility of the United States Office of Personnel Management with respect to Administrative Law Judges, including their testing, selection, and appointment Draft legislation to amend various adjudication provisions of the Administrative Procedure Act Legislative recommendations related to: attorney-client privilege and the Rules Enabling Act H.R. 2661, the Court Security Enhancement Act of 2009 H.R. 1515, to assist courts in the States and territories with improving the administration of justice H.Res. 473, Expressing the sense of the House of Representatives that judicial determinations regarding the meaning of the Constitution of the United States should not be based on judgments, laws, or pronouncements of foreign institutions unless such foreign judgments, laws, or pronouncements inform an understanding of the original meaning of the Constitution of the United States. H.R. 1107, To enact certain laws relating to public contracts as title 41, United States Code, "Public Contracts" Draft legislation to encourage greater use of federal agency E-rulemaking (electronic rulemaking) Proposed appointment of new Chair or Acting Chair and other proposed start-up activities for the newly reconstituted Administrative Conference of the United States H.R. 2850, the Administrative Law Judges Retirement Act of 2009-legislation that would provide for enhanced retirement benefits for administrative law judges

Follow developments within the Administration relating to global health policies concerning U.S. government participation in WHO and UN health initiatives; international public health issues; U.S. sanctions policies; international vaccine issues; vaccine policy at the Pan American Health Organization; Childhood immunizations Dietary supplement issues Alzheimer's care Pediatric Studies and Trials Drug Safety/Clinical Trials Health care reform legislation FDA Pre-emption Follow-on biologics Drug importation and counterfeiting Drug advertising Comparative effectiveness Physician payment disclosure Chronic care out of pocket costs Vaccine Program H.R. 1427 - Access to Life-Saving Medicine Act H.R. 1548 - The Pathway for Biosimilars Act Legislative and regulatory issues related to hormone replacement therapies International public health issues International vaccine issues H.R. 1/S350 - The American Recovery and Reinvestment Act of 2009 H.R. 579 - The Food and Drug Administration Globalization Act S. 525/H.R. 1298 - The Pharmaceutical Market Access and Drug Safety Act of 2009 S. 301 - Physican Payments Sunshine Act of 2009 H.R. 573 - Authorized Generics S. 501 - Fair Prescription Drug Competition Act S. 369 - Preserve Access to Affordable Generics Act H.R. 1706 - Protecting consumer Access to Generic Drugs Act S.357 - Sunshine in Litigation Act of 2009 H.R. 3200 - American's Affordable Health Choices Act of 2009 S.1679 Affordable Health Choices Act S.1213 - Patient Centered Outcomes Research Act of 2009

Client expense: $681,738 · Firm income: Not reported

Drug safety and drug counterfeiting including H.R. 579, the Food and Drug Administration Globalization Act; Drug importation including S. 525/H.R. 1298, the Pharmaceutical Market Access and Drug Safety Act of 2009; S. 1232, Pharmaceutical Market Access and Drug Safety Act of 2009; Follow-on biologics including H.R. 1548, the Pathway to Biosimilars Act; S. 726/H.R. 1427, Promoting Innovation and Access to Life-Saving Medicines Act; Physician payment disclosure including S. 301, Physician Payments Sunshine Act of 2009; Comparative effectiveness including H.R. 1, the American Recovery and Reinvestment Act; S.1213, Patient-Centered Outcomes Research Act of 2009; Health information technology including H.R. 1, the American Recovery and Reinvestment Act; Authorized generics including H.R. 573; S. 501, Fair Prescription Drug Competition Act; Drug company settlements including S. 369, Preserve Access to Affordable Generics Act; H.R. 1706, Protecting Consumer Access to Generic Drugs Act; Health care reform including H.R. 3200, America's Affordable Health Choices Act; S___, Affordable Health Choices Act; and S. ___, America's Healthy Future Act; Prescription drug advertising; Federal preemption for prescription drugs; and Legislation concerning civil litigation including S. 357, Sunshine in Litigation Act of 2009.

Client expense: Not reported · Firm income: $80,000

Drug safety and drug counterfeiting including H.R. 579, the Food and Drug Administration Globalization Act; Drug importation including S. 525/H.R. 1298, the Pharmaceutical Market Access and Drug Safety Act of 2009; S. 1232, Pharmaceutical Market Access and Drug Safety Act of 2009; Follow-on biologics including H.R. 1548, the Pathway to Biosimilars Act; S. 726/H.R. 1427, Promoting Innovation and Access to Life-Saving Medicines Act; Physician payment disclosure including S. 301, Physician Payments Sunshine Act of 2009; Comparative effectiveness including H.R. 1, the American Recovery and Reinvestment Act; S. 1259, Preserving Access to Targeted, Individualized, and Effective New Treatments and Services Act of 2009; S. 1213, Patient-Centered Outcomes Research Act of 2009; Health information technology including H.R. 1, the American Recovery and Reinvestment Act; Authorized generics including H.R. 573; S. 501, Fair Prescription Drug Competition Act; Drug company settlements including S. 369, Preserve Access to Affordable Generics Act; H.R. 1706, Protecting Consumer Access to Generic Drugs Act; Health care reform including H.R. 3200, America's Affordable Health Choices Act; S.___, Affordable Health Choices Act; and S.___, America's Healthy Future Act; Prescription drug advertising; Federal preemption for prescription drugs; Legislation affecting telemedicine including H.R. 1, the American Recovery and Reinvestment Act; and Legislation concerning civil litigation including S. 357, Sunshine in Litigation Act of 2009.

Client expense: Not reported · Firm income: $20,000

Drug safety and drug counterfeiting including H.R. 579, the Food and Drug Administration Globalization Act; Drug importation including S. 525/H.R. 1298, the Pharmaceutical Market Access and Drug Safety Act of 2009; S. 1232, Pharmaceutical Market Access and Drug Safety Act of 2009; Follow-on biologics including H.R. 1548, the Pathway to Biosimilars Act; S. 726/H.R. 1427, Promoting Innovation and Access to Life-Saving Medicines Act; Physician payment disclosure including S. 301, Physician Payments Sunshine Act of 2009; Comparative effectiveness including H.R. 1, the American Recovery and Reinvestment Act; S. 1213, Patient-Centered Outcomes Research Act of 2009; Health information technology including H.R. 1, the American Recovery and Reinvestment Act; Authorized generics including H.R. 573; S. 501, Fair Prescription Drug Competition Act; Drug company settlements including S. 369, Preserve Access to Affordable Generics Act; H.R. 1706, Protecting Consumer Access to Generic Drugs Act; Health care reform including H.R. 3200, America's Affordable Health Choices Act; S.___, Affordable Health Choices Act; and S.___, America's Healthy Future Act; Stem cell research including S. 487/H.R. 873, Stem Cell Research Enhancement Act of 2009; Prescription drug advertising; Federal preemption for prescription drugs; and Legislation concerning civil litigation including S. 357, Sunshine in Litigation Act of 2009.

Client expense: Not reported · Firm income: $50,000

Drug safety and drug counterfeiting including H.R. 579, the Food and Drug Administration Globalization Act; Drug importation including S. 525/H.R. 1298, the Pharmaceutical Market Access and Drug Safety Act of 2009; S. 1232, Pharmaceutical Market Access and Drug Safety Act of 2009; Follow-on biologics including H.R. 1548, the Pathway to Biosimilars Act; S. 726/H.R. 1427, Promoting Innovation and Access to Life-Saving Medicines Act; Physician payment disclosure including S. 301, Physician Payments Sunshine Act of 2009; Comparative effectiveness including H.R. 1, the American Recovery and Reinvestment Act; S. 1213, Patient-Centered Outcomes Research Act of 2009; Health information technology including H.R. 1, the American Recovery and Reinvestment Act; Authorized generics including H.R. 573; S. 501, Fair Prescription Drug Competition Act; Drug company settlements indlucing S. 369, Preserve Access to Affordable Generics Act; H.R. 1706, Protecting Consumer Access to Generic Drugs Act; Health care reform including Affordable Health Choices Act, H.R. 3200, America's Affordable Health Choices Act, and America's Healthy Future Act; Prescription drug advertising; Federal preemption for prescription drugs; and Legislation concerning civil litigation including S. 357, Sunshine in Litigation Act of 2009.

Client expense: Not reported · Firm income: $80,000

Drug Sentencing Reform and Cocaine Kingpin Trafficking Act (HR 265) - all provisions; Fairness in Cocaine Sentencing Act (HR 1459) - all provisions; Juvenile Justice and Delinquency Prevention Reauthorization Act (S. 678) - all provisions; Fight Fraud Act (HR 1748) - all provisions; Money Laundering Correction Act (HR 1743) - all provisions; Equal Justice for Our Military Act (S. 357, HR 569) - all provisions; State Secrets Protection Act (S. 417) - all provisions; U.S. Patriot Act and Domestic Surveillance Laws; Indigent Defense, Overcriminalization; Juvenile Justice Accountability and Improvement Act (HR 2289) - all provisions; National Criminal Justice Commission Act (S. 714) - all provisions; Deferred Prosecution Agreements and Non-Prosecution Agreements.

Client expense: $50,000 · Firm income: Not reported

Government targets: Bureau of Justice Assistance, HOUSE OF REPRESENTATIVES, Justice, Dept of (DOJ), SENATE

H.R. 429, S. 446, A bill to permit the televising of Supreme Court proceedings. S. 657, Sunshine in the Courtroom Act of 2009 H.R. 1626, S. 630, Statutory Time-Periods Technical Amendments Act of 2009 H.R. 156, Stop the Congressional Pay Raise Act H.R. 215, Congressional Pay Reform Act of 2009 H.R. 282, Delay Congressional Pay Raise Act S. 102, S. 317, S. 620, A bill to repeal the provision of law that provides automatic pay adjustments for Members of Congress. H.R. 191, Ninth Circuit Court of Appeals Judgeship and Reorganization Act of 2009 S. 220, H.R. 486, Judicial Transparency and Ethics Enhancement Act of 2009 HR 569, S.357 -- Equal Justice for the Military Act (provides service members with the same opportunity that the government has to petition the Supreme Court for review of a court martial that carries serious consequences to the Supreme Court H.R. 984, S. 417, the State Secrets Protection Act H.R. 157, S. 160, the District of Columbia House Voting Rights Act of 2009 S. 718, Civil Access to Justice Act of 2009 Draft legislation to establish a new Administrative Law Judge Conference of the United States as an independent agency to assume the responsibility of the United States Office of Personnel Management with respect to Administrative Law Judges, including their testing, selection, and appointment Draft legislation to amend various adjudication provisions of the Administrative Procedure Act P.L. 110-343, formerly, H.R. 1424, Emergency Economic Stabilization Act Section 114 (Market Transparency) relating to possible future federal agency regulations leading to waiver of attorney-client privilege and work product protections Legislative recommendations related to: attorney-client privilege and the Rules Enabling Act H.R. 2661, the Court Security Enhancement Act of 2009 H.R. 1515, to assist courts in the States and territories with improving the administration of justice H.Res. 473, Expressing the sense of the House of Representatives that judicial determinations regarding the meaning of the Constitution of the United States should not be based on judgments, laws, or pronouncements of foreign institutions unless such foreign judgments, laws, or pronouncements inform an understanding of the original meaning of the Constitution of the United States. H.R. 1272, To provide for the conversion of a temporary judgeship for the district of Hawaii to a permanent judgeship. S. 193, A bill to create and extend certain temporary district court judgeships. Final Rule on Identity Theft Red Flags and Address Discrepancies Under the Fair and Accurate Credit Transactions Act of 2003, 16 C.F.R. 681.1 (2007)proposed Federal Trade Commission finding and/or draft legislation clarifying that the rule is not applicable to lawyers providing legal services to clients H.R. 1107, To enact certain laws relating to public contracts as title 41, United States Code, "Public Contracts" Draft legislation to encourage greater use of federal agency E-rulemaking (electronic rulemaking) Proposed appointment of new Chair or Acting Chair and other proposed start-up activities for the newly reconstituted Administrative Conference of the United States

Follow developments within the Administration relating to global health policies concerning U.S. government participation in WHO and UN health initiatives; international public health issues; U.S. sanctions policies; international vaccine issues; vaccine policy at the Pan American Health Organization; Childhood immunizations Dietary supplement issues Alzheimer's care Pediatric Studies and Trials Drug Safety/Clinical Trials Health care issues Health care reform legislation Drug approvals Reimbursement rates FDA Pre-emption Follow-on biologics Drug importation and counterfeiting Drug advertising Comparative effectiveness Physician payment disclosure Chronic care out of pocket costs Vaccine Program H.R. 1427 - Access to Life-Saving Medicine Act H.R. 1548 - The Pathway for Biosimilars Act Legislative and regulatory issues related to hormone replacement therapies International public health issues International vaccine issues H.R. 1/S350 - The American Recovery and Reinvestment Act of 2009 H.R. 579 - The Food and Drug Administration Globalization Act S. 525/H.R. 1298 - The Pharmaceutical Market Access and Drug Safety Act of 2009 S. 301 - Physican Payments Sunshine Act of 2009 H.R. 573 - Authorized Generics S. 501 - Fair Prescription Drug Competition Act S. 369 - Preserve Access to Affordable Generics Act H.R. 1706 - Protecting consumer Access to Generic Drugs Act S.357 - Sunshine in Litigation Act of 2009 H.R. 3200 - American's Affordable Health Choices Act of 2009 S. ___ Affordable Health Choices Act S.1213 - Patient Centered Outcomes Research Act of 2009

Client expense: $901,191 · Firm income: Not reported

Drug safety and drug counterfeiting including H.R. 579, the Food and Drug Administration Globalization Act; Drug importation including S. 525/H.R. 1298, the Pharmaceutical Market Access and Drug Safety Act of 2009; S. 1232, Pharmaceutical Market Access and Drug Safety Act of 2009; Follow-on biologics including H.R. 1548, the Pathway to Biosimilars Act; S. 726/H.R. 1427, Promoting Innovation and Access to Life-Saving Medicines Act; Physician payment disclosure including S. 301, Physician Payments Sunshine Act of 2009; Comparative effectiveness including H.R. 1, the American Recovery and Reinvestment Act; S.1213, Patient-Centered Outcomes Research Act of 2009; Health information technology including H.R. 1, the American Recovery and Reinvestment Act; Authorized generics including H.R. 573; S. 501, Fair Prescription Drug Competition Act; Drug company settlements including S. 369, Preserve Access to Affordable Generics Act; H.R. 1706, Protecting Consumer Access to Generic Drugs Act; Health care reform including the Affordable Health Choices Act; Prescription drug advertising; Federal preemption for prescription drugs; and Legislation concerning civil litigation including S. 357, Sunshine in Litigation Act of 2009.

Client expense: Not reported · Firm income: $60,000

Drug safety and drug counterfeiting including H.R. 579, the Food and Drug Administration Globalization Act; Drug importation including S. 525/H.R. 1298, the Pharmaceutical Market Access and Drug Safety Act of 2009; S. 1232, Pharmaceutical Market Access and Drug Safety Act of 2009; Follow-on biologics including H.R. 1548, the Pathway to Biosimilars Act; S. 726/H.R. 1427, Promoting Innovation and Access to Life-Saving Medicines Act; Physician payment disclosure including S. 301, Physician Payments Sunshine Act of 2009; Comparative effectiveness including H.R. 1, the American Recovery and Reinvestment Act; S. 1259, Preserving Access to Targeted, Individualized, and Effective New Treatments and Services Act of 2009; S. 1213, Patient-Centered Outcomes Research Act of 2009; Health information technology including H.R. 1, the American Recovery and Reinvestment Act; Authorized generics including H.R. 573; S. 501, Fair Prescription Drug Competition Act; Drug company settlements including S. 369, Preserve Access to Affordable Generics Act; H.R. 1706, Protecting Consumer Access to Generic Drugs Act; Health care reform including the Affordable Health Choices Act; Prescription drug advertising; Federal preemption for prescription drugs; Legislation affecting telemedicine including H.R. 1, the American Recovery and Reinvestment Act; and Legislation concerning civil litigation including S. 357, Sunshine in Litigation Act of 2009.

Client expense: Not reported · Firm income: $120,000

Drug safety and drug counterfeiting including H.R. 579, the Food and Drug Administration Globalization Act; Drug importation including S. 525/H.R. 1298, the Pharmaceutical Market Access and Drug Safety Act of 2009; S. 1232, Pharmaceutical Market Access and Drug Safety Act of 2009; Follow-on biologics including H.R. 1548, the Pathway to Biosimilars Act; S. 726/H.R. 1427, Promoting Innovation and Access to Life-Saving Medicines Act; Physician payment disclosure including S. 301, Physician Payments Sunshine Act of 2009; Comparative effectiveness including H.R. 1, the American Recovery and Reinvestment Act; S. 1213, Patient-Centered Outcomes Research Act of 2009; Health information technology including H.R. 1, the American Recovery and Reinvestment Act; Authorized generics including H.R. 573; S. 501, Fair Prescription Drug Competition Act; Drug company settlements including S. 369, Preserve Access to Affordable Generics Act; H.R. 1706, Protecting Consumer Access to Generic Drugs Act; Health care reform including the Affordable Health Choices Act; Stem cell research including S. 487/H.R. 873, Stem Cell Research Enhancement Act of 2009; Prescription drug advertising; Federal preemption for prescription drugs; and Legislation concerning civil litigation including S. 357, Sunshine in Litigation Act of 2009.

Client expense: Not reported · Firm income: $50,000

Drug safety and drug counterfeiting including H.R. 579, the Food and Drug Administration Globalization Act; Drug importation including S. 525/H.R. 1298, the Pharmaceutical Market Access and Drug Safety Act of 2009; S. 1232, Pharmaceutical Market Access and Drug Safety Act of 2009; Follow-on biologics including H.R. 1548, the Pathway to Biosimilars Act; S. 726/H.R. 1427, Promoting Innovation and Access to Life-Saving Medicines Act; Physician payment disclosure including S. 301, Physician Payments Sunshine Act of 2009; Comparative effectiveness including H.R. 1, the American Recovery and Reinvestment Act; S. 1213, Patient-Centered Outcomes Research Act of 2009; Health information technology including H.R. 1, the American Recovery and Reinvestment Act; Authorized generics including H.R. 573; S. 501, Fair Prescription Drug Competition Act; Drug company settlements indlucing S. 369, Preserve Access to Affordable Generics Act; H.R. 1706, Protecting Consumer Access to Generic Drugs Act; Health care reform including the Affordable Health Choices Act; Prescription drug advertising; Federal preemption for prescription drugs; and Legislation concerning civil litigation including S. 357, Sunshine in Litigation Act of 2009.

Client expense: Not reported · Firm income: $80,000

Follow developments within the Administration relating to global health policies concerning U.S. government participation in WHO and UN health initiatives; international public health issues; U.S. sanctions policies; international vaccine issues; vaccine policy at the Pan American Health Organization; Childhood immunizations Dietary supplement issues Alzheimer's care Pediatric Studies and Trials Drug Safety/Clinical Trials Health care issues Health care reform legislation Drug approvals Reimbursement rates FDA Pre-emption Follow-on biologics Drug importation and counterfeiting Drug advertising Comparative effectiveness Physician payment disclosure Hormone replacement therapies Chronic care out of pocket costs Federal preemption Vaccine Program H.R. 1427 - Access to Life-Saving Medicine Act H.R. 1548 - The Pathway for Biosimilars Act Legislative and regulatory issues related to bioidentical hormone replacement therapies International public health issues International vaccine issues H.R. 1/S350 - The American Recovery and Reinvestment Act of 2009 H.R. 579 - The Food and Drug Administration Globalization Act S. 525/H.R. 1298 - The Pharmaceutical Market Access and Drug Safety Act of 2009 S. 301 - Physican Payments Sunshine Act of 2009 H.R. 573 - Authorized Generics S. 501 - Fair Prescription Drug Competition Act S. 369 - Preserve Access to Affordable Generics Act H.R. 1706 - Protecting consumer Access to Generic Drugs Act S.357 - Sunshine in Litigation Act of 2009 Federal preemption for prescription drugs

Client expense: $876,339 · Firm income: Not reported

H.R. 429, S. 446, A bill to permit the televising of Supreme Court proceedings. S. 657, Sunshine in the Courtroom Act of 2009 S. 630, Statutory Time-Periods Technical Amendments Act of 2009 H.R. 156, Stop the Congressional Pay Raise Act H.R. 215, Congressional Pay Reform Act of 2009 H.R. 282, Delay Congressional Pay Raise Act S. 102, S. 317, S. 620, A bill to repeal the provision of law that provides automatic pay adjustments for Members of Congress. H.R. 191, Ninth Circuit Court of Appeals Judgeship and Reorganization Act of 2009 S. 220, H.R. 486, Judicial Transparency and Ethics Enhancement Act of 2009 HR 569, S.357 -- Equal Justice for the Military Act (provides service members with the same opportunity that the government has to petition the supreme court for review of a court martial that carries serious consequences to the Supreme court S. 417, State Secrets Protection Act H.R. 157, S. 160, the District of Columbia House Voting Rights Act of 2009 S. 718, Civil Access to Justice Act of 2009 Draft legislation to establish a new Administrative Law Judge Conference of the United States as an independent agency to assume the responsibility of the United States Office of Personnel Management with respect to Administrative Law Judges, including their testing, selection, and appointment Draft legislation to amend various adjudication provisions of the Administrative Procedure Act P.L. 110-343, formerly, H.R. 1424, Emergency Economic Stabilization Act Section 114 (Market Transparency) relating to possible future federal agency regulations leading to waiver of attorney-client privilege and work product protections Urged the OPM and to use its authority to make locality adjustments to the basic pay of administrative law judges (ALJs) and to grant ALJs the same national pay raise that is expected to be authorized for the General Schedule for fiscal year 2009. Legislative recommendations related to: attorney-client privilege and the Rules Enabling Act

Drug safety and drug counterfeiting including H.R. 579, the Food and Drug Administration Globalization Act; Drug importation including S. 525/H.R. 1298, the Pharmaceutical Market Access and Drug Safety Act of 2009; Follow-on biologics including H.R. 1548, the Pathway to Biosimilars Act; S. 726/H.R. 1427, Promoting Innovation and Access to Life-Saving Medicines Act; Physician payment disclosure including S. 301, Physician Payments Sunshine Act of 2009; Comparative effectiveness including H.R. 1, the American Recovery and Reinvestment Act; Health information technology including H.R. 1, the American Recovery and Reinvestment Act; Authorized generics including H.R. 573; S. 501, Fair Prescription Drug Competition Act; Drug company settlements including S. 369, Preserve Access to Affordable Generics Act; H.R. 1706, Protecting Consumer Access to Generic Drugs Act; Health care reform; Prescription drug advertising; Federal preemption for prescription drugs; and Legislation concerning civil litigation including S. 357, Sunshine in Litigation Act of 2009.

Client expense: Not reported · Firm income: $50,000

Drug safety and drug counterfeiting including H.R. 579, the Food and Drug Administration Globalization Act; Drug importation including S. 525/H.R. 1298, the Pharmaceutical Market Access and Drug Safety Act of 2009; Follow-on biologics including H.R. 1548, the Pathway to Biosimilars Act; S. 726/H.R. 1427, Promoting Innovation and Access to Life-Saving Medicines Act; Physician payment disclosure including S. 301, Physician Payments Sunshine Act of 2009; Comparative effectiveness including H.R. 1, the American Recovery and Reinvestment Act; Health information technology including H.R. 1, the American Recovery and Reinvestment Act; Authorized generics including H.R. 573; S. 501, Fair Prescription Drug Competition Act; Drug company settlements including S. 369, Preserve Access to Affordable Generics Act; H.R. 1706, Protecting Consumer Access to Generic Drugs Act; Health care reform; Prescription drug advertising; Federal preemption for prescription drugs; Legislation affecting telemedicine including H.R. 1, the American Recovery and Reinvestment Act; and Legislation concerning civil litigation including S. 357, Sunshine in Litigation Act of 2009.

Client expense: Not reported · Firm income: $60,000

Drug safety and drug counterfeiting including H.R. 579, the Food and Drug Administration Globalization Act; Drug importation including S. 525/H.R. 1298, the Pharmaceutical Market Access and Drug Safety Act of 2009 Follow-on biologics including H.R. 1548, the Pathway to Biosimilars Act; S. 726/H.R. 1427, Promoting Innovation and Access to Life-Saving Medicines Act; Physician payment disclosure including S. 301, Physician Payments Sunshine Act of 2009; Comparative effectiveness including H.R. 1, the American Recovery and Reinvestment Act; Health information technology including H.R. 1, the American Recovery and Reinvestment Act; Authorized generics including H.R. 573; S. 501, Fair Prescription Drug Competition Act; Drug company settlements including S. 369, Preserve Access to Affordable Generics Act; H.R. 1706, Protecting Consumer Access to Generic Drugs Act; Health care reform; Stem cell research including S. 487/H.R. 873, Stem Cell Research Enhancement Act of 2009; Prescription drug advertising; Federal preemption for prescription drugs; and Legislation concerning civil litigation including S. 357, Sunshine in Litigation Act of 2009.

Client expense: Not reported · Firm income: $100,000

Drug safety and drug counterfeiting including H.R. 579, the Food and Drug Administration Globalization Act; Drug importation including S. 525/H.R. 1298, the Pharmaceutical Market Access and Drug Safety Act of 2009; Follow-on biologics including H.R. 1548, the Pathway to Biosimilars Act; S. 726/H.R. 1427, Promoting Innovation and Access to Life-Saving Medicines Act; Physician payment disclosure including S. 301, Physician Payments Sunshine Act of 2009; Comparative effectiveness including H.R. 1, the American Recovery and Reinvestment Act; Health information technology including H.R. 1, the American Recovery and Reinvestment Act; Authorized generics including H.R. 573; S. 501, Fair Prescription Drug Competition Act; Drug company settlements indlucing S. 369, Preserve Access to Affordable Generics Act; H.R. 1706, Protecting Consumer Access to Generic Drugs Act; Health care reform; Prescription drug advertising; Federal preemption for prescription drugs; and Legislation concerning civil litigation including S. 357, Sunshine in Litigation Act of 2009.

Client expense: Not reported · Firm income: $80,000